In a recent issue of Alimentary Pharmacology & Therapeutics, Sunwoo and colleagues published the results of a phase 1 study of DWP14012, a new potassium‐competitive acid blocker (P‐CAB).1 The advent of the P‐CABs marks the latest development in our ability to control gastric acid secretion. The dawn of the 20th century began with the statement “No acid, no ulcer,”2 heralding massive efforts to control acid secretion by the stomach since peptic ulcer was a major cause of morbidity and mortality.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile